Legius E, Dierick H, Wu R, Hall BK, Marynen P, Cassiman JJ, et al
Research context: For evidence on mechanisms, human and preclinical research, limitations, and safety, read Retatrutide Peptide: Benefits, Uses, Side Effects, Dosage, and Research
What Recent Research and Regulatory Updates Show A 2024 Danish study found that adults with type 2 diabetes who used semaglutide once a week were more than twice as likely to develop NAION within five years compared with non-users (HR 2.19), with a median onset of 22 months after starting the medication
When to Consider Alternative Options For some individuals, there are times when the side effects can overshadow the advantages of the drugs
BMJ (2017) 359:j4849